Valuation : Sagittarius Life Science Corp

Market Cap 319.83Cr 10Cr 8.69Cr 8.2Cr 7.47Cr 14Cr 965.92Cr 14Cr 98Cr 38Cr 489.93Cr 38Cr 37Cr 1.56TCr P/E 2024
-21.4x
P/E 2025 -55.9x
Enterprise Value 239.51Cr 7.57Cr 6.51Cr 6.14Cr 5.59Cr 10Cr 723.35Cr 11Cr 73Cr 28Cr 366.9Cr 28Cr 28Cr 1.17TCr EV / Sales 2024
1.9x
EV / Sales 2025 7.69x
Free-Float
29.82%
Yield 2024 *
-
Yield 2025 -
14/08 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
14/05 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
16/03 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2025 CI
13/11 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
12/25/12 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
14/25/14 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
13/25/13 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2024 CI
14/24/14 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
13/24/13 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
15/24/15 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
21/24/21 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2023 CI
14/23/14 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
14/23/14 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
1 day+1.18%
1 week+0.64%
Current month+0.74%
1 month-5.49%
3 months-11.33%
6 months-8.06%
Current year-7.70%
1 week 46
Extreme 46
47.4
1 month 45.8
Extreme 45.8
50.8
Current year 45.8
Extreme 45.8
67
1 year 43.95
Extreme 43.95
67
3 years 21.3
Extreme 21.3
67
5 years 20.65
Extreme 20.65
79.2
10 years 20.65
Extreme 20.65
167
Manager TitleAgeSince
Chief Executive Officer - 30/09/2019
Director of Finance/CFO - 15/11/2019
Director TitleAgeSince
Chairman - 29/04/2004
Director/Board Member - 17/06/2015
Director/Board Member - 29/04/2004
Change 5-day change 1-year change 3-year change Capi.($)
+1.18%+0.64%-13.75%+11.15% 10Cr
+0.67%+1.65%+11.95%+67.34% 1.23TCr
+2.18%-3.64%-23.88%+275.87% 865.82Cr
-3.37%-2.97%-22.14%-49.84% 244.4Cr
-1.73%+1.66%-16.37%-5.50% 152.61Cr
-0.13%+0.11%+22.93%+78.77% 136.73Cr
-2.77%+0.90%+32.19%-15.78% 132.37Cr
-1.38%-10.58%-74.70%-77.17% 109.65Cr
-3.45%-11.17%-45.69% - 107.06Cr
-1.44%-10.88%-62.28%-68.64% 92Cr
Average -1.02%-3.17%-19.17%+24.02% 308.44Cr
Weighted average by Cap. +0.19%-1.59%-8.23%+101.75%

Financials

2024 2025
Net sales 47Cr 1.48Cr 1.27Cr 1.2Cr 1.09Cr 2.04Cr 141.27Cr 2.06Cr 14Cr 5.5Cr 72Cr 5.55Cr 5.43Cr 227.59Cr 35Cr 1.09Cr 94.02L 88.71L 80.81L 1.51Cr 104.52Cr 1.52Cr 11Cr 4.07Cr 53Cr 4.11Cr 4.02Cr 168.39Cr
Net income -4.85Cr -15.33L -13.18L -12.44L -11.33L -21.18L -15Cr -21.38L -1.48Cr -57.02L -7.43Cr -57.57L -56.31L -24Cr -4.96Cr -15.66L -13.46L -12.7L -11.57L -21.64L -15Cr -21.83L -1.51Cr -58.23L -7.59Cr -58.79L -57.51L -24Cr
Net Debt -15Cr -47.43L -40.79L -38.48L -35.06L -65.53L -45Cr -66.13L -4.58Cr -1.76Cr -23Cr -1.78Cr -1.74Cr -73Cr -80Cr -2.54Cr -2.18Cr -2.06Cr -1.88Cr -3.51Cr -242.56Cr -3.54Cr -25Cr -9.44Cr -123.03Cr -9.53Cr -9.32Cr -390.79Cr
Logo Sagittarius Life Science Corp
Sagittarius Life Science Corp. is a Taiwan-based company principally engaged in the research, development, production and sales of health products. The Company's main products include various types of nutrition and health formulations, natural and organic food, beverages, probiotic fermentation products, beauty care ingredients, Chinese herbal medicines, plant new medicines and health supplies. The Company also provides related technical services for the research and development of Chinese and western pharmaceutical products. The Company distributes its products in domestic market and to overseas markets, such as the rest areas of Asia and the Americas.
Employees
112
Date Price Change Volume
10/26/10 NT$47.35 +1.18% 24,025
09/26/09 NT$46.80 0.00% 12,055
08/26/08 NT$46.80 0.00% 18,010
07/26/07 NT$46.80 +1.30% 8,155
04/26/04 NT$46.20 -1.81% 1,14,509
  1. Stock Market
  2. Stocks
  3. 3205 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!